Already at best price
Nadformin-GV2 Tablet SR
Glimepiride (2mg) + Voglibose (0.2mg) + Metformin (500mg)
Nadans Lifesciences
Anti-Diabetic
₹138.60
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
₹138.60
Active composition
Glimepiride 2 mg
+2 more active ingredients
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medicine Strength
2 mg
All Active Ingredients
Glimepiride2 mg
Voglibose0.2 mg
Metformin500 mg
Uses & Benefits
Medical applications
Diabetes
Nadformin-GV2 Tablet SR is a combination extended-release pharmaceutical formulation intended for the management of type 2 diabetes mellitus. The triple therapy comprises Glimepiride (2mg), Metformin (500mg), and Voglibose (0.2mg). Glimepiride is a sulfonylurea that stimulates insulin secretion, while Metformin reduces hepatic glucose production and intestinal absorption. Voglibose, an alpha-glucosidase inhibitor, delays carbohydrate absorption in the small intestine. This comprehensive medication aims to control blood glucose levels effectively in patients with type 2 diabetes, thereby reducing the risk of long-term complications. However, it is crucial to follow prescribed dosages and monitor blood glucose levels regularly under medical supervision due to the potential for adverse effects and interactions with other medications.
Dosage & How to Use
How to use Nadformin-GV Tablet SR Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Nadformin-GV2 Tablet SR is to be taken with food.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
✓Only 2.3% reported effects
Common Side Effects
Headache8%
Nausea5%
Higher
Lower
Safety Advice
Alcohol
It is unsafe to consume alcohol with Nadformin-GV2 Tablet SR.
High Risk
Pregnancy
Nadformin-GV2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Nadformin-GV2 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Nadformin-GV2 Tablet SR may be needed. Please consult your doctor. Nadformin-GV2 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Nadformin-GV2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Nadformin-GV2 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Nadformin-GV2 Tablet SR is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Nadformin-GV2 Tablet SR
Nadformin-GV2 Tablet SR
1 / 3
Rx RequiredSchedule H
Nadformin-GV2 Tablet SR
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
₹138.60
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
Cheaper alternative availability
Not Foundfor this medicine
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Glimepiride 2 mg
+2 more active ingredients
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medicine Strength
2 mg
All Active Ingredients
Glimepiride2 mg
Voglibose0.2 mg
Metformin500 mg
Uses & Benefits
Medical applications
Diabetes
Nadformin-GV2 Tablet SR is a combination extended-release pharmaceutical formulation intended for the management of type 2 diabetes mellitus. The triple therapy comprises Glimepiride (2mg), Metformin (500mg), and Voglibose (0.2mg). Glimepiride is a sulfonylurea that stimulates insulin secretion, while Metformin reduces hepatic glucose production and intestinal absorption. Voglibose, an alpha-glucosidase inhibitor, delays carbohydrate absorption in the small intestine. This comprehensive medication aims to control blood glucose levels effectively in patients with type 2 diabetes, thereby reducing the risk of long-term complications. However, it is crucial to follow prescribed dosages and monitor blood glucose levels regularly under medical supervision due to the potential for adverse effects and interactions with other medications.
Dosage & How to Use
How to use Nadformin-GV Tablet SR Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Nadformin-GV2 Tablet SR is to be taken with food.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
✓Only 2.3% reported effects
Common Side Effects
Headache8%
Nausea5%
Higher
Lower
Safety Advice
Alcohol
It is unsafe to consume alcohol with Nadformin-GV2 Tablet SR.
High Risk
Pregnancy
Nadformin-GV2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Nadformin-GV2 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Nadformin-GV2 Tablet SR may be needed. Please consult your doctor. Nadformin-GV2 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Nadformin-GV2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Nadformin-GV2 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Nadformin-GV2 Tablet SR is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Nadformin-GV2 Tablet SR
%22%2F%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22158%22%20font-family%3D%22system-ui%2C-apple-system%2CSegoe%20UI%2CRoboto%2Csans-serif%22%20font-size%3D%2244%22%20font-weight%3D%22800%22%20text-anchor%3D%22middle%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.45%22%20transform%3D%22rotate(-16%20150%20158)%22%3EDrugIndia%3C%2Ftext%3E%0A%3Cg%20fill%3D%22%23fb7185%22%20opacity%3D%220.5%22%3E%3Cpath%20d%3D%22M44%2048h6v6h6v6h-6v6h-6v-6h-6v-6h6z%22%2F%3E%3Cpath%20d%3D%22M250%20214h5v5h5v5h-5v5h-5v-5h-5v-5h5z%22%2F%3E%3C%2Fg%3E%0A%3Cellipse%20cx%3D%22150%22%20cy%3D%22120%22%20rx%3D%22118%22%20ry%3D%2286%22%20fill%3D%22url(%23glow)%22%2F%3E%0A%3Cg%20transform%3D%22rotate(-28%20150%20120)%22%20filter%3D%22url(%23soft)%22%20font-family%3D%22system-ui%2C-apple-system%2CSegoe%20UI%2CRoboto%2Csans-serif%22%3E%0A%3Crect%20x%3D%2289%22%20y%3D%2297%22%20width%3D%22122%22%20height%3D%2246%22%20rx%3D%2223%22%20fill%3D%22url(%23cap)%22%2F%3E%0A%3Cpath%20d%3D%22M89%20120a23%2023%200%200%201%2023-23h38v46h-38a23%2023%200%200%201-23-23z%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.16%22%2F%3E%0A%3Cline%20x1%3D%22150%22%20y1%3D%2298%22%20x2%3D%22150%22%20y2%3D%22142%22%20stroke%3D%22%23ffffff%22%20stroke-width%3D%222%22%20opacity%3D%220.55%22%2F%3E%0A%3Cellipse%20cx%3D%22118%22%20cy%3D%22110%22%20rx%3D%2215%22%20ry%3D%225%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.4%22%2F%3E%0A%3C%2Fg%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22206%22%20font-size%3D%2222%22%20font-weight%3D%22700%22%20letter-spacing%3D%220.2%22%20text-anchor%3D%22middle%22%20fill%3D%22%237c2d12%22%3ESITARAY%20M%3C%2Ftext%3E%3Ctext%20x%3D%22150%22%20y%3D%22232%22%20font-size%3D%2222%22%20font-weight%3D%22700%22%20letter-spacing%3D%220.2%22%20text-anchor%3D%22middle%22%20fill%3D%22%237c2d12%22%3E50%2F500MG%20TAB%3C%2Ftext%3E%0A%3Cg%20font-family%3D%22system-ui%2C-apple-system%2CSegoe%20UI%2CRoboto%2Csans-serif%22%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22271%22%20font-size%3D%2215%22%20font-weight%3D%22800%22%20letter-spacing%3D%221.5%22%20text-anchor%3D%22middle%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.85%22%3EDRUGINDIA%3C%2Ftext%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22270%22%20font-size%3D%2215%22%20font-weight%3D%22800%22%20letter-spacing%3D%221.5%22%20text-anchor%3D%22middle%22%20fill%3D%22%23c2410c%22%3EDRUGINDIA%3C%2Ftext%3E%0A%3C%2Fg%3E%0A%3C%2Fsvg%3E)